|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-10-21
|
|
pubmed:abstractText |
Drug-eluting stents, since their approval in the United States, have become the treatment of choice for de novo coronary artery narrowing due to their ability to reduce restenosis and the need for repeat revascularization. We present two patients who underwent percutaneous coronary intervention for the treatment of multivessel coronary artery disease; both patients were treated with sirolimus-eluting stents (SES) and bare metal stents (BMS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1522-1865
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
173-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16237987-Adult,
pubmed-meshheading:16237987-Angioplasty, Balloon, Coronary,
pubmed-meshheading:16237987-Coronary Artery Disease,
pubmed-meshheading:16237987-Coronary Thrombosis,
pubmed-meshheading:16237987-Humans,
pubmed-meshheading:16237987-Immunosuppressive Agents,
pubmed-meshheading:16237987-Male,
pubmed-meshheading:16237987-Platelet Aggregation Inhibitors,
pubmed-meshheading:16237987-Sirolimus,
pubmed-meshheading:16237987-Stents,
pubmed-meshheading:16237987-Treatment Refusal,
pubmed-meshheading:16237987-Withholding Treatment
|
|
pubmed:articleTitle |
Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy.
|
|
pubmed:affiliation |
Division of Cardiology, Washington Hospital Center, DC 20010, USA.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
